Last Price$8.79NASDAQ Previous Close - Last Trade as of 3:58PM ET 5/24/22

Today's Change-0.45(4.87%)
Bid (Size)$8.81 (5)
Ask (Size)$8.82 (63)
Day Low / High$8.69 - 9.10
Volume819.0 K

View Biotechnology IndustryPeer Comparison as of 05/24/2022


Alector Inc ( NASDAQ )

Price: $8.79
Change: -0.45 (4.87%)
Volume: 819.0 K
3:58PM ET 5/24/2022

NanoString Technologies Inc ( NASDAQ )

Price: $15.64
Change: -0.91 (5.50%)
Volume: 752.0 K
3:58PM ET 5/24/2022

Editas Medicine Inc ( NASDAQ )

Price: $9.99
Change: -0.90 (8.26%)
Volume: 1.3 M
3:58PM ET 5/24/2022

Avid Bioservices Inc ( NASDAQ )

Price: $12.38
Change: +0.27 (2.23%)
Volume: 758.0 K
3:58PM ET 5/24/2022

Deciphera Pharmaceuticals Inc ( NASDAQ )

Price: $10.76
Change: -0.97 (8.27%)
Volume: 1.0 M
3:58PM ET 5/24/2022

Read more news Recent News

--Barclays Adjusts Alector's Price Target to $14 from $42, Keeps Overweight Rating
12:37PM ET 5/11/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Alector Shares Fall After Goldman Sachs Starts Coverage at Sell
12:47PM ET 4/13/2022 MT Newswires

Alector (ALEC) shares were down nearly 2% in Wednesday afternoon trade after Goldman Sachs initiated coverage of the stock at sell while setting the price...

--Goldman Sachs Initiates Coverage on Alector With Sell Rating, $9 Price Target
5:31AM ET 4/13/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Alector Names Chief Medical Officer
5:29PM ET 3/29/2022 MT Newswires

Alector (ALEC) said Tuesday that it has named Dr. Gary Romano as chief medical officer, effective May 23. According to the company, Romano will lead the...

View all Commentary and Analysis

Hypotheses Underlying Alzheimer's Drug Development
1:06PM ET 4/26/2022 Seeking Alpha

Alector: Expect Phase 3 Data Next Year
3:26AM ET 4/16/2022 Seeking Alpha

Alector (ALEC) Investor Presentation - Slideshow
1:45AM ET 3/31/2022 Seeking Alpha

Alector (ALEC) Presents Twelve Month Results
2:20PM ET 3/23/2022 Seeking Alpha

Company Profile

Business DescriptionAlector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA. View company web site for more details
Address131 Oyster Point Boulevard
South San Francisco, California 94080-2029
Number of EmployeesN/A
Recent SEC Filing04/28/2022DEF 14A
Chief Executive Officer & DirectorArnon Rosenthal
President, Head-Research & DevelopmentSaraswati Kenkare-Mitra
Chief Financial, Accounting & Business OfficerMarc Edward Grasso
VP-Technology & Digital HealthCharles Wolfus

Company Highlights

Price Open$9.00
Previous Close$9.24
52 Week Range$7.50 - 43.32
Market Capitalization$732.4 M
Shares Outstanding83.3 M
SectorHealth Technology
Next Earnings Announcement08/02/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.43
Beta vs. S&P 500N/A
Revenue$27.7 M
Net Profit Margin-12.65%
Return on Equity-10.57%

Analyst Ratings as of 04/11/2022

Consensus RecommendationConsensus Icon
Powered by Factset